BTC $79,171.00 -0.91%
ETH $2,490.37 -0.11%
BNB $739.35 -1.38%
XRP $1.39 -1.21%
SOL $103.90 -1.93%
TRX $0.3343 -0.28%
DOGE $0.0898 +0.38%
ADA $0.2193 -0.22%
BCH $260.43 +1.61%
LINK $12.74 +3.06%
HYPE $85.01 -3.03%
AAVE $131.75 -1.04%
SUI $0.8250 +3.84%
XLM $0.1898 +3.37%
ZEC $1,153.60 -5.89%
BTC $79,171.00 -0.91%
ETH $2,490.37 -0.11%
BNB $739.35 -1.38%
XRP $1.39 -1.21%
SOL $103.90 -1.93%
TRX $0.3343 -0.28%
DOGE $0.0898 +0.38%
ADA $0.2193 -0.22%
BCH $260.43 +1.61%
LINK $12.74 +3.06%
HYPE $85.01 -3.03%
AAVE $131.75 -1.04%
SUI $0.8250 +3.84%
XLM $0.1898 +3.37%
ZEC $1,153.60 -5.89%

US stock MEIP rose over 33% today, with a market value reaching 41.24 million USD

2025-07-19 00:18:45

ChainCatcher news, according to market news, MEI Pharma (NASDAQ: MEIP) rose over 33% today, with a market capitalization reaching $41.2431 million.

Previously, it was reported that Titan Partners Group and crypto investment firm GSR are jointly leading a strategic transformation for the American pharmaceutical company MEI Pharma (NASDAQ: MEIP), promoting the establishment of a dedicated Litecoin treasury strategy. Currently, over $100 million in funding commitments have been made for this project. Litecoin founder Charlie Lee has agreed to join the board of MEI Pharma.

app_icon
ChainCatcher Building the Web3 world with innovations.